Neurology and Mental Clinic of the Medical University of Pécs (1963-1978) National Institute of Psychiatry and Neurology (1978-2007)
Péter Gaszner (4 August 1939 – 25 July 2017) was a Hungarian psychiatrist, chief physician of the National Institute of Psychiatry and Neurology in Hungary, and professor of the Semmelweis University in Budapest.
Personal life
The parents of Gaszner are László Gaszner (Komádi, November 4, 1904 – 1983) and Marianne Barkóczy Klopsch (Budapest, March 15, 1908 – 2003), a highschool teacher. His paternal grandparents were Károly Gaszner and Mária Kugler and his maternal grandparents were Béla Barkóczy (1872–1957) and Róza Buday (1882–1974). He completed his schools in Békéscsaba and Diósgyőr, later in the Újdiósgyőr High School.[1] He received his medical degree from the Medical University of Debrecen. His children are Andrea (born 1965), Balázs (born 1969), Gábor (born 1978), and Mariann (born 1984). Three of his children became doctors; Mariann chose a career in economics. Gaszner rests in the Barkóczy-Gaszner crypt in Eger, in the Hatvani Cemetery (next to Szépasszony Valley).[2]
Career
After a short detour in Miskolc, he became a neurologist between 1963 and 1978 and then a psychiatrist at the Neurology and Mental Clinic of the Medical University of Pécs under the supervision of Professor Környey. For most of his career, from 1978 to 2007, he worked in the psychiatric department of the National Institute of Psychiatry and Neurology in Budapest. He spent twenty years of his more than 45-year teaching career as a professor at Semmelweis University, where he habilitated in 1995.
He was the chief physician of the National Institute of Psychiatry and Neurology (OPNI, Lipótmező) between 1908 and 2007, until the closure of the institute. He led a class of one hundred and forty people.[3]
His specialties were: sleep disorder, panic disorder, phobia, depression, manic depression, anxiety disorders, sleep disorder, alcohol and individual life problems, relationship disorders, crisis situations, integration problems, obsessive-compulsive disorder, mood disorders, schizophrenia, menstrual disorders. For example, phobias and related anxiety disorders are the most common forms of mental illness, occurring in 20 to 40 percent of the population. 2.5-3 percent of the domestic population may suffer from obsessive-compulsive disorder. Schizophrenia occurs in 0.7-1% of the Hungarian population. These diseases can now be cured, more precisely, asymptomatic can be ensured if the patient cooperates with the doctor. In 2002, Péter Gaszner, on the healing effectiveness of psychiatry, said: “It is no coincidence that I was talking about asymptomatic and not healing. We can cure a disease for which we know for sure. Psychiatric treatments are not comparable to the effectiveness of treatments used in physical medicine. People's mental difficulties cannot be solved with chemicals. Drugs administered in psychiatry only serve to chemically suppress unpleasant mental manifestations, but this does not help the person to overcome their mental difficulty in the long run. It's no coincidence that when medicated patients stop taking the drug, they “relapse”: their symptoms recur, which psychiatrists usually say, “they haven't taken their medication long enough,” but in reality, these drugs don't restore the drug. mental health and only suppress the symptoms for as long as they are taken.”[7][8] Péter Gaszner was the president of the Hungarian Society of Psychopharmacology, as he specialized in psychopharmacology, as the pharmacological treatment of nerve and mental illnesses has significantly transformed therapy since the 1950s. Chlorpromazine was first discovered. From the 1970s, when selective compounds appeared, development accelerated even more. Péter Gaszner successfully used traditional psychotherapy in combination with medication. His research in this area was published, inter alia, in 1989, entitled “Pharmacological Treatment of Mental Illnesses”. He summarized it in his 139-page book.[9]
Selected works
Mózsik Gyula, Gaszner Péter , Ludány Andrea és Jávor Tibor: Az egyszeri intravénásan adott, nagy dózisú (30,0-600,0 mg) atropin hatása az emberi gyomorsecretióra.( Effect of single intravenous high dose atropine (30.0-600.0 mg) on human gastric secretion) Orvosi Hetilap, 1974. szeptember (115. évfolyam) 1974-09-01 / 35.szám. szám[10]
Bódis Lóránt, Gaszner Péter és Radnai Béla: Nagy dózisú (50.0-600.0 mg) intravénásán adott atropin hatása a szívműködésre. (Effect of high-dose (50.0-600.0 mg) intravenous atropine on cardiac function) Orvosi Hetilap, 1976. március (117. évfolyam) 1976-03-28 / 13. szám.[11]
Gaszner Péter-Thomas A. Ban. CODE-HD : composite diagnostic evaulation of hyperthymic disorders CODE-HD : composite diagnostic evaulation of hyperthymic disorders; Bp., Animula. 1998.
„The soul-diseases medication treatment” In Hungarian); Bp., HungáriaSport RMV Nyomda. 1989.
Gaszner Péter-Uriel Halbreich-Gustav Hoffmann. Psychiatry and the Law - Central European Psychiatry; Kiadó. Lundbeck Hungária Kft. Bp., 2000.
Gaszner Péter- Ban Thomas A.: Complex diagnostic evaluation of hyperthyroid disorders; (In Hungarian); Kiadó Kalm-R Bt. 2007.Prospectus. In Hungarian[12]
CODE-HD : composite diagnostic evaulation of hyperthymic disorders A hyperthymiás zavarok komplex diagnosztikai értékelése = Composite diagnostic evaluation of hyperthymic disorders : CODE-HD / Gaszner Péter & Thomas. Kalmár Sándor, Kalmár Koppány. Kecskemét. Kalm-R Bt., 2007.
Web of Science[13] He publishes his first-ever “A” category publication in 37 international journals[14]
Evaluation of his scientific work
1. Péter Gaszner's recommendation for the academic title. 2000. Recommended academics: hu:Knoll József, Magyar Kálmán. Magyar Tudomány – A MTA folyóirata, 2000 (107. kötet = Új folyam 45. kötet) 2000 / 12. sz.[15]
2. Péter Gaszner's recommendation for the academic title. 2003. Recommended academics: József Knoll, Kálmán Magyar, Emil Pásztor[16] Részletek: “After his neuropathological work, he developed a procedure for uncomplicated atropine coma. He found that occasionally a hundred times the “usual” toxic dose could be given as a single parenteral dose. He was the first to describe the mechanism of the cholinergic and noradrenergic nervous system effects of antidepressants and neuroleptics in healthy volunteers and patients (Br. J. Clin. Pharmac., 9,112-113, 1980; Br. J. Clin. Pharmac. 9, 88-91, 1980). His new polydiagnostic nosological system, the Composite Diagnostic Evaluation of Hyperthymic Disorders (Gaszner, Ban; Animula, Budapest, 1998), is the most reliable method of psychiatric classification today. He was the first to describe the antidepressant selective reboxetine and the healing effect of clonazepam on drug withdrawal symptoms, sitting. the safety and novel use of clozapine (Progr. Neuro-Psychopharmac. Biol. Psychiat. 26, 603-607, 2002). His research work was primarily in the field of psychiatric and clinical psychopharmacology. 204, resp. his book chapter is in English. Impact factor: 61,298. He organized twelve international congresses and the CINP World Congress. !! ” Although he deserved the title of academician, he was not elected an academician by the Hungarian Academy of Sciences.